Seagen announces preliminary results from phase 2 clinical trial of adcetris® (brentuximab vedotin) in novel combination of agents for patients with advanced stage classical hodgkin lymphoma

Bothell, wash.--(business wire)-- #ash2021--seagen announces preliminary results from phase 2 trial of adcetris® in novel combination of agents for patients with advanced stage hodgkin lymphoma
SGEN Ratings Summary
SGEN Quant Ranking